Inspira Technologies (IINN) announced the completion of the first human treatment using its U.S. Food and Drug Administration-cleared INSPIRA ART100 system in a critical life-support procedure. The procedure was performed by expert physicians at Westchester Medical Center in New York State, marking the first real-world implementation of Inspira’s innovative technology. During the life-support procedure, the INSPIRA ART100 effectively provided comprehensive heart and lung support by oxygenating and circulating the patient’s blood. Following the procedure, the patient was safely transitioned off the system, demonstrating its effective support. The installation, training program and professional services relating to the clinical use of the INSPIRA ART100 was led by Glo-Med.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IINN:
- Inspira Technologies’ INSPIRA ART100 systems installed in U.S. hospital
- Inspira Technologies Announces Sales Agreement to Boost Financial Flexibility
- Inspira Technologies Announces Major Advances in Respiratory Care
- Inspira Technologies Faces Nasdaq Compliance Challenge
- Inspira Technologies Reports 2024 Financial Results and Key Developments